FDA Strengthens Warning Labels on Class of Antibacterial Drugs
The Food and Drug Administration (FDA) announced on Tuesday, 7/26 that they are revising their boxed warning labels on packages of a class of antibacterial drugs known as fluoroquinolones. The FDA’s boxed warning labels, commonly referred to as “black box” warnings, alert doctors and patients that certain types of drugs or medical devices may pose …
